Sulfamoxole Inhibitor

MBS5756742 is an inhibitor targeting Sulfamoxole. Sulfamoxole is an antibacterial belonging to sulfonamide.

Velluti F, Mosconi N, Acevedo A, Borthagaray G, Castiglioni J, Faccio R, Back DF, Moyna G, Rizzotto M, Torre MH. Synthesis, characterization, microbiological evaluation, genotoxicity and synergism tests of new nano silver complexes with sulfamoxole: X-ray diffraction of [Ag2(SMX)2]-DMSO. J Inorg Biochem. 2014 Dec;141:58-69. doi: 10.1016/j.jinorgbio.2014.08.007. Epub 2014 Aug 19. PubMed PMID: 25217718.
Gruneberg RN. In vitro studies with combinations of sulfamoxole and trimethoprim (co-trifamole). Curr Med Res Opin. 1982;8(2):128-33. PubMed PMID: 7105824.
Gupta KC, Desai NK, Paul T, Sheth UK. Plasma levels of trimethoprim and sulfonamide after administration of trimethoprim-sulfamethoxazole and trimethoprim-sulfamoxole. Int J Clin Pharmacol Ther Toxicol. 1980 Dec;18(12):536-7. PubMed PMID: 7228448.
Praharaj SC, Kar AK. Non controlled clinical trial of trimethoprim and sulfamoxole (supristol) in bacterial diarrhoea of children. Indian J Pediatr. 1979 Nov;46(382):411-6. PubMed PMID: 546760.

Small volumes of Sulfamoxole, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.